- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/02 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 235/02
Total number of patents in this class: 412
10-year publication summary
|
16
|
30
|
35
|
33
|
33
|
23
|
12
|
24
|
16
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gruenenthal GmbH | 105 |
16 |
| Glaxo Group Limited | 4063 |
10 |
| AstraZeneca AB | 2892 |
10 |
| Boehringer Ingelheim International GmbH | 4642 |
10 |
| LG Chem, Ltd. | 17635 |
9 |
| Vitae Pharmaceuticals, Inc. | 96 |
9 |
| The Regents of the University of California | 19961 |
8 |
| Allergan, Inc. | 2347 |
7 |
| Medshine Discovery Inc. | 598 |
7 |
| Reata Pharmaceuticals, Inc. | 123 |
7 |
| The University of Queensland | 661 |
7 |
| BASF SE | 20940 |
6 |
| Grünenthal GmbH | 565 |
6 |
| Ligand Pharmaceuticals Incorporated | 171 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
6 |
| Merck Sharp & Dohme Corp. | 2191 |
5 |
| Memorial Sloan-Kettering Cancer Center | 1931 |
5 |
| Bristol-myers Squibb Company | 4880 |
4 |
| Janssen Pharmaceutica N.V. | 3394 |
4 |
| President and Fellows of Harvard College | 5986 |
4 |
| Other owners | 266 |